Innocar 150 mg Injection Substitute
Composition:
CARBOPLATIN-150MG
Uses:
Ovarian cancer and Small cell lung cancer
Medicinal Benefits:
Innocar 150 mg Injection contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
Innocar 150 mg Injection contains 'Carboplatin'. Carboplatin works by breaching the cellular wall and binding to the cell’s DNA, preventing the cell from dividing and functioning normally, which eventually kills the cell.
Yes, Innocar 150 mg Injection can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.
Innocar 150 mg Injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
Before you receive treatment with Innocar 150 mg Injection, tell your doctor about all of your medical conditions. You should not receive Innocar 150 mg Injection if you are allergic to carboplatin or any contents in Innocar 150 mg Injection. It should not be employed in patients with severe bone marrow depression or significant bleeding.
If not given an inappropriate dose, Innocar 150 mg Injection can cause toxic effects, although not everyone gets it. So, Innocar 150 mg Injection is prescribed by a doctor experienced in the use of medications to treat cancer only.
Avoid taking Innocar 150 mg Injection if you are pregnant because Innocar 150 mg Injection can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Innocar 150 mg Injection.